Golumbeski George — SEC Form 4 filings
SEC reporting owner CIK 1586660. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-11 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sage Therapeutics, Inc. (SAGE) | Director | 3 | — | — | 5 |
| Mural Oncology plc (MURA) | Director | 3 | — | — | 4 |
| Acumen Pharmaceuticals, Inc. (ABOS) | Director | 2 | — | — | 3 |
| Shattuck Labs, Inc. (STTK) | Director | 3 | — | — | 3 |
Form 4 filings — Golumbeski George
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/award (A): 35,500 @ $0 · Grant/award (A): 53,250 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 81,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Mural Oncology plc (MURA) | Disposition to issuer (D): 8,637 (derivative) · Disposition to issuer (D): 15,334 (derivative) | EDGAR |
| 2025-11-10 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Sage Therapeutics, Inc. (SAGE) | Code (U): 8,000 · Disposition to issuer (D): 13,593 (derivative) · Disposition to issuer (D): 21,500 (derivative) | EDGAR |
| 2025-07-16 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 33,150 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Mural Oncology plc (MURA) | Grant/award (A): 8,637 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 21,500 (derivative) @ $0 | EDGAR |
| 2024-07-31 | 4 | Mural Oncology plc (MURA) | Grant/award (A): 15,334 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 27,700 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1586660 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →